Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers. - Wikidata - awgldk - TriplyDB

Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.

Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.

http://www.wikidata.org/entity/Q36946778

about

Generating Cell Targeting Aptamers for Nanotheranostics Using Cell-SELEX Development of Cell-SELEX Technology and Its Application in Cancer Diagnosis and Therapy Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.Selection and characterization of DNA aptamer against glucagon receptor by cell-SELEX.Current Advances in Aptamers for Cancer Diagnosis and Therapy.Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.Aptamer Cell-Based Selection: Overview and Advances.Aptamers: novelty tools for cancer biology.Aptamers as Diagnostic Tools in Cancer

P2860

Q26744825-B6BA42F2-691F-49EE-9300-630F304839B0 Q28080168-E356120C-4091-4DE6-B379-A0841AD462AC Q33832781-5484AB5E-51C3-4A77-B0CA-EC10F9E9DFB4 Q37697065-E6DA032E-9BE6-40AD-84A0-CD954436731A Q38287579-6530DF92-6F0E-460F-83AD-80FE9C418BD5 Q47561686-D3973D1F-1251-4F2E-BE91-17A9ADD63495 Q49545795-6838245A-8471-4CE3-AC01-18BA1D1EA426 Q52544489-BB07F4CB-07A9-45AA-8436-ED6AB1218BC8 Q55285633-0E87DA12-3483-4314-897D-364A90FDC68B Q58749805-36263D0D-0CBA-4E4F-93DA-A46592681620

P2860

Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.

http://www.wikidata.org/entity/Q36946778

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Identification of an aptamer t ...... high metastatic liver cancers.

@en

type

label

Identification of an aptamer t ...... high metastatic liver cancers.

@en

prefLabel

Identification of an aptamer t ...... high metastatic liver cancers.

@en

P1433

Q36946778-E9A43921-DA77-43B5-A148-D2C0999EE3EE

P1476

Q36946778-8606EDBF-14EE-41DA-95A7-0167C428BD09

P2093

Q36946778-0633886C-0DBA-4A64-81F3-F568817DBF07

Q36946778-068DA1CD-6D4C-41F4-B996-D60B87912E84

Q36946778-25E95F2B-B78F-4D18-86DE-A524B4780E2C

Q36946778-7C72A10B-65A2-4B2B-9783-F4FED45B56F3

Q36946778-7EFBA4E8-4D5C-472D-A66C-22DFC71A4850

Q36946778-BA4785E7-8661-4B43-84B0-653944150898

Q36946778-F7EF014B-9055-490E-8B7D-6F4B509C1D7B

Q36946778-FA864E12-4C51-43F4-AE2D-9434ED8E5093

P2860

Q36946778-097E45F7-121A-4411-B563-ABD06AC5BC41

Q36946778-1E4DB53A-A9FF-44B4-9903-FCE3E6C9724E

Q36946778-2C9477E5-D121-4580-9A38-B51D7D100938

Q36946778-3A1962E5-49C9-4F1F-997A-0CA2D204F1AA

Q36946778-40BB1275-4FA2-4243-9CB7-9D3EBD792118

Q36946778-48E6BAFF-F654-4DFF-B383-62C04B9D7777

Q36946778-49CB6003-2511-4556-8030-7CCA787A4CA5

Q36946778-4F1D9523-78AB-41F1-9006-8C1B87D55A83

Q36946778-50A505F8-CBC6-468C-A257-2961BC33BDE3

Q36946778-50DD64B9-58EA-4FBD-991D-70C451C15862

P304

Q36946778-B1A5F1F7-B4AA-4651-B5F2-EA082D638E47

P31

Q36946778-33222946-6836-4098-A901-E39A033D9DCD

P356

Q36946778-5E371DF8-DCB7-4081-B5B2-D5EE25A58401

P407

Q36946778-75F539EA-E319-41AE-AEF5-320BE42E45E8

P433

Q36946778-288FE396-3350-4956-BEC5-FF7E9CDCDF12

P478

Q36946778-280CE247-5388-4974-BCA7-49A924765B94

P577

Q36946778-CB77DA32-4D3F-47B9-83A0-348727789532

P698

Q36946778-C32B0CEB-20F7-4551-BD59-BE7DAA91B032

P932

Q36946778-8BEFA3A1-0E73-4C5F-9484-71F46F8569C0

P356

ONCOTARGET.6988

P1433

P1476

Identification of an aptamer t ...... high metastatic liver cancers.

@en

P2093

Bi-Cheng Wang

http://www.w3.org/2001/XMLSchema#string

Chang-Qing Yin

http://www.w3.org/2001/XMLSchema#string

Chun-Wei Peng

http://www.w3.org/2001/XMLSchema#string

Fu-Bing Wang

http://www.w3.org/2001/XMLSchema#string

Hao Chen

http://www.w3.org/2001/XMLSchema#string

Shao-Ping Liu

http://www.w3.org/2001/XMLSchema#string

Xue-Feng Zhou

http://www.w3.org/2001/XMLSchema#string

Yuan Rong

http://www.w3.org/2001/XMLSchema#string

P2860

A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment

Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase

Cancer invasion and the microenvironment: plasticity and reciprocity

Inhibition of cell proliferation by an anti-EGFR aptamer

Differential SELEX in human glioma cell lines

Tumor metastasis: molecular insights and evolving paradigms

Aptamers and their biological applications

From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis.

Characterization of anti-NF-kappaB RNA aptamer-binding specificity in vitro and in the yeast three-hybrid system.

Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach.

P304

8282-8294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.6988

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26882565

http://www.w3.org/2001/XMLSchema#string

P932

4884992

http://www.w3.org/2001/XMLSchema#string